$20.29
0.64 (+3.26%)
Insulet Corp (NASDAQ:PODD)
CAPS Rating:
Dvlp,mftr,mkt insulin infusion system for diabetes
The World's Greatest Investing Community
Dvlp,mftr,mkt insulin infusion system for diabetes
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Not a market guy, but a manufacturing guy. Insulet was my account up until last year when the printed circuit board company I worked for finally gave up to offshore pressure. I knew a lot of these guys and I am amazed this company has not taken off like a rocket. Never opened a Schwab account before but did for this group and closed it when I thought they couldn't figure out how to get out of their own way. One of life's disapointments. Insulet needs to figure out how to stop spending and start making money. A top notch product I know well. Good luck - when the price point is back in the $12's will take another look. There were a whole list of meds this pump was slated to dispense.